Services
Development Services
Formulation
Solubility & Bioavailability Enhancement
Micro and Nanotechnology
Drug / Device Combination Products
Biopharmaceutical
Proprietary Technology
Feasibility Programs
Manufacturing Services
Aseptic Manufacturing
Pre-clinical Manufacturing
Clinical Manufacturing
Commercial Manufacturing
ICH Stability Programs
Analytical Services
Analytical Method Development and Validation
Drug Release Testing
Physical Characterization
Stability Indicating Method Development
Dosage Forms
Solutions and Suspensions
Implantable Drug Delivery Systems and Combination Products
Microparticle and Gel Depot Injections
Oral Solid Dose
Semi-Solids and Gels
Powders
Markets Served
Ophthalmic
Long-Acting Drug Delivery
Oral Drug Delivery
Topical, Mucosal, and Transdermal
Injectables / Parenteral
Resource Center
Our Blog
Webinars / Presentations
Technical Briefs
Guides
About Us
Case Studies
Employment
Events
Management Team
Press Releases
Published Articles
Scientific Publications
Contact Us
Services
Development Services
Formulation
Solubility & Bioavailability Enhancement
Micro and Nanotechnology
Drug / Device Combination Products
Biopharmaceutical
Proprietary Technology
Feasibility Programs
Manufacturing Services
Aseptic Manufacturing
Pre-clinical Manufacturing
Clinical Manufacturing
Commercial Manufacturing
ICH Stability Programs
Analytical Services
Analytical Method Development and Validation
Drug Release Testing
Physical Characterization
Stability Indicating Method Development
Dosage Forms
Solutions and Suspensions
Implantable Drug Delivery Systems and Combination Products
Microparticle and Gel Depot Injections
Oral Solid Dose
Semi-Solids and Gels
Powders
Markets Served
Ophthalmic
Long-Acting Drug Delivery
Oral Drug Delivery
Topical, Mucosal, and Transdermal
Injectables / Parenteral
Resource Center
Our Blog
Webinars / Presentations
Technical Briefs
Guides
About Us
Case Studies
Employment
Events
Management Team
Press Releases
Published Articles
Scientific Publications
Contact Us
Resource Center
Featured Post
How to Select the Right CDMO for Your Sterile Drug Product
Learn More
Blog
What to Expect From Your Nanomilling Partner or Company
How to Enhance the Solubility of Ocular Drug Products
How to Select the Right CDMO for Your Sterile Drug Product
Solving Bioavailability Challenges Using A Drug Product’s Target Product Profile (TPP)
View All >
Presentations/Webinars
Designing Drug/Device Combination Products Quickly & Efficiently with Pathway™ TPU
Clinical to Commercial Manufacturing: Selecting the Right CDMO for Your Sterile Drug Product
Overcoming Challenges in Ophthalmic Drug Delivery including Bioavailability and Sterility
Insoluble APIs Scaring You? Don’t Be Afraid of Nanotechnology!
View All >
Published Articles
Parenteral Drug Delivery Trends
Improving Bioavailability & Solubility: Each Molecule Is Unique
Solubility and Bioavailability Enhancement Techniques
Long-Acting Drug Delivery: Injections, Implants, and Combination Products
View All >
Technical Briefs
Incorporation of Dexamethasone Into Silicone Drug-Device Combination Products
Combination Products for Medical Device Developers
Lyophilization of Complex Drug Products: Formulation Challenges and Scale-Up
Manufacturing Sterile Products
View All >
